Koya Medical
Private Company
Total funding raised: $30M
Overview
Koya Medical is a commercial-stage medical device company targeting the significant unmet needs in venous and lymphatic care. Its core innovation is the Dayspring system, a wearable, non-pneumatic compression therapy designed for the management of lymphedema and chronic venous insufficiency, which has demonstrated superior edema reduction and patient adherence versus traditional pneumatic compression in clinical studies. The company is building a portfolio around its active compression technology, with additional pipeline programs (K9, K1, TissueIQ) aimed at expanding into adjacent vascular indications. Koya operates as a private company, leveraging clinical evidence and a direct commercial strategy to capture share in a large, underserved market.
Technology Platform
Proprietary active, non-pneumatic compression therapy utilizing flexible, wearable structures that provide dynamic compression enabling patient mobility.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Koya competes in the compression therapy market against large, established players like Tactile Medical (pneumatic pumps), Arjo, and Bio Compression, as well as numerous makers of passive compression garments. Its primary competitive edge is the unique mobile, non-pneumatic technology which directly targets the major flaw of incumbent solutions: poor patient adherence. It also faces potential future competition from other innovators in wearable medical devices.